{"data":{"id":"us/21-cfr-601.30","jurisdiction":"us","citation":"21 CFR 601.30","heading":"Scope.","body":"This subpart applies to radiopharmaceuticals intended for in vivo administration for diagnostic and monitoring use. It does not apply to radiopharmaceuticals intended for therapeutic purposes. In situations where a particular radiopharmaceutical is proposed for both diagnostic and therapeutic uses, the radiopharmaceutical must be evaluated taking into account each intended use.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER F—BIOLOGICS","PART 601—LICENSING","Subpart D—Diagnostic Radiopharmaceuticals"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"4b3c1875ae2ba196fdd0881e5fa41a8ff00fc08502af0b4ff26cb7f0df933918","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-601.29","next":"us/21-cfr-601.31"},"notice":"GroundRules: Original legal text. Not legal advice."}